Search for Clinical Trials

This is a Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2 or 3 prior…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Leukemia
Back to topback-to-top